Surrozen, Inc. Warrant

SRZNW

...

SRZNW: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Show SRZNW Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of SRZNW by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by SRZNW's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on SRZNW's company Twitter account

WallStreetBets

Number of mentions of SRZNW in WallStreetBets Daily Discussion

SRZNW News

Recent insights relating to SRZNW

CNBC Recommendations

Recent picks made for SRZNW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SRZNW

Corporate Flights

Flights by private jets registered to SRZNW